HuGE Literature Finder
Records
1
-
13
| Oncogene mutational analysis in Chinese gastrointestinal stromal tumor patients. OncoTargets and therapy 2018 11 2279-2286. Chen Qiong, Li Rong, Zhang Zhi-Gao, Deng Qiao-Ting, Li Kun, Wang Hao, Yang Xue-Xi, Wu Ying-So |
| Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events. Human pathology 2017 Jan . Huss Sebastian, Pasternack Hlen, Ihle Michaela Angelika, Merkelbach-Bruse Sabine, Heitkötter Birthe, Hartmann Wolfgang, Trautmann Marcel, Gevensleben Heidrun, Büttner Reinhard, Schildhaus Hans-Ulrich, Wardelmann E |
| Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2016 May . Capelli L, Petracci E, Quagliuolo V, Saragoni L, Colombo P, Morgagni P, Calistri D, Tomezzoli A, Di Cosmo M, Roviello F, Vindigni C, Coniglio A, Villanacci V, Catarci M, Coppola L, Alfieri S, Ricci R, Capella C, Rausei S, Gulino D, Amadori D, Ulivi P, |
| Molecular cytology genotyping of primary and metastatic GI stromal tumors by using a custom two-gene targeted next-generation sequencing panel with therapeutic intent. Gastrointestinal endoscopy 2016 Apr . Gleeson Ferga C, Kerr Sarah E, Kipp Benjamin R, Voss Jesse S, Minot Douglas M, Tu Zheng Jin, Henry Michael R, Vasmatzis George, Cheville John C, Lazaridis Konstantinos N, Levy Michael |
| KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based study. The American journal of surgical pathology 2015 Jul 39 (7): 922-30. Rossi Sabrina, Gasparotto Daniela, Miceli Rosalba, Toffolatti Luisa, Gallina Giovanna, Scaramel Enrico, Marzotto Alessandra, Boscato Elena, Messerini Luca, Bearzi Italo, Mazzoleni Guido, Capella Carlo, Arrigoni Gianluigi, Sonzogni Aurelio, Sidoni Angelo, Mariani Luigi, Amore Paola, Gronchi Alessandro, Casali Paolo G, Maestro Roberta, Dei Tos Angelo |
| Kinase genotype analysis of gastric gastrointestinal stromal tumor cytology samples using targeted next-generation sequencing. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2015 Jan 13 (1): 202-6. Gleeson Ferga C, Kipp Benjamin R, Kerr Sarah E, Voss Jesse S, Graham Rondell P, Campion Michael B, Minot Douglas M, Tu Zheng J, Klee Eric W, Lazaridis Konstantinos N, Henry Michael R, Levy Michael |
| Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors: a population-based study. World journal of surgical oncology 2015 13 47. Rubió-Casadevall Jordi, Borràs Joan Lluis, Carmona-García Maria Carme, Ameijide Alberto, Gonzalez-Vidal Allan, Ortiz Maria Rosa, Bosch Ramon, Riu Francesc, Parada David, Martí Esther, Miró Josefina, Sirvent Juan Jose, Galceran Jaume, Marcos-Gragera Rafa |
| Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors. European journal of human genetics : EJHG 2013 May 21 (5): 503-10. Celestino Ricardo, Lima Jorge, Faustino Alexandra, Vinagre João, Máximo Valdemar, Gouveia António, Soares Paula, Lopes José Manu |
| No KRAS mutations found in gastrointestinal stromal tumors (GISTs): molecular genetic study of 514 cases. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2013 May . Lasota J, Xi L, Coates T, Dennis R, Evbuomwan MO, Wang ZF, Raffeld M, Miettinen M |
| Molecular characterization of an Italian series of sporadic GISTs. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2013 Jan . Origone P, Gargiulo S, Mastracci L, Ballestrero A, Battistuzzi L, Casella C, Comandini D, Cusano R, Dei Tos AP, Fiocca R, Garuti A, Ghiorzo P, Martinuzzi C, Toffolatti L, Bianchi Scarrà G |
| Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1. Proceedings of the National Academy of Sciences of the United States of America 2012 Jul 109 (31): E2127-33. Ohashi Kadoaki, Sequist Lecia V, Arcila Maria E, Moran Teresa, Chmielecki Juliann, Lin Ya-Lun, Pan Yumei, Wang Lu, de Stanchina Elisa, Shien Kazuhiko, Aoe Keisuke, Toyooka Shinichi, Kiura Katsuyuki, Fernandez-Cuesta Lynnette, Fidias Panos, Yang James Chih-Hsin, Miller Vincent A, Riely Gregory J, Kris Mark G, Engelman Jeffrey A, Vnencak-Jones Cindy L, Dias-Santagata Dora, Ladanyi Marc, Pao Willi |
| KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Mar 18 (6): 1769-76. Miranda Claudia, Nucifora Martina, Molinari Francesca, Conca Elena, Anania Maria Chiara, Bordoni Andrea, Saletti Piercarlo, Mazzucchelli Luca, Pilotti Silvana, Pierotti Marco A, Tamborini Elena, Greco Angela, Frattini Mi |
| Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors. Genes, chromosomes & cancer 2008 Oct 47 (10): 853-9. Agaram Narasimhan P, Wong Grace C, Guo Tianhua, Maki Robert G, Singer Samuel, Dematteo Ronald P, Besmer Peter, Antonescu Cristina |
- Page last reviewed:Jul 25, 2022
- Page last updated:Dec 02, 2022
- Content source: